← brief for 2026-09-13 · Slowing decline

Safety and Synergy of Finerenone and Empagliflozin in Lowering Blood Pressure.

Key takeaways

Finerenone and empagliflozin are two drugs that protect the kidneys, and they are often prescribed together in kidney disease with diabetes. This report asks whether taking both lowers blood pressure more than either alone, and whether the pair is safe together. It comes from a university repository, not a peer reviewed journal, and the abstract was not available. So the study design, the number of people, and the size of any blood pressure drop are all unknown here. Treat it as something to watch for in published form, not as an answer.

Who did this work

Csaba P. Kövesdy · Meike Brinker · Peter Rossing · Amy K. Mottl (University of North Carolina at Chapel Hill) · Julio Rosenstock · Masaomi Nangaku · Ricardo Correa‐Rotter · Janet B. McGill · Hiddo J.L. Heerspink · Sankar D. Navaneethan · Johannes F E Mann · Jennifer B. Green

Source

Paper · OpenAlex, CKD works · 2026-09-11
https://doi.org/10.17615/zdpr-qz93